Back
Citius Oncology Stock Price Chart
Sponsored
CTOR
Sponsored
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
45
CTOR
Citius Oncology
Last Price:
1.40
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- The current trend is relatively stagnant and CTOR is experiencing slight selling pressure.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.58 | Sell |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.53 | Sell |
20-day EMA: | 1.34 | Buy |
50-day EMA: | 0.84 | Buy |
200-day EMA: | 0.27 | Buy |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 27.99 | Sell |
Chaikin Money Flow: | -3335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Citius Oncology Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
- Citius Oncology share price is 1.40 while CTOR 8-day simple moving average is 1.58, which is a Sell signal.
- The stock price of CTOR is 1.40 while Citius Oncology 20-day SMA is 0.00, which makes it a Buy.
- Citius Oncology 50-day simple moving average is 0.00 while CTOR share price is 1.40, making it a Buy technically.
- CTOR stock price is 1.40 and Citius Oncology 200-day simple moving average is 0.00, creating a Buy signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
45
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a Sell
The current Citius Oncology [CTOR] share price is $1.40. The Score for CTOR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology Stock Info
Market Cap:
99.74M
Price in USD:
1.40
Share Volume:
163.41K
Citius Oncology 52-Week Range
52-Week High:
4.42
52-Week Low:
1.30
Sell
45
Citius Oncology (CTOR)
is a Sell
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?
The Citius Oncology stock price is 1.40 USD today. -
Will CTOR stock go up or go down?
Citius Oncology> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Oncology overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is overvalued.
Is Citius Oncology Stock a Buy?
- Citius Oncology share price is 1.40 while CTOR 8-day exponential moving average is 1.53, which is a Sell signal.
- The stock price of CTOR is 1.40 while Citius Oncology 20-day EMA is 1.34, which makes it a Buy.
- Citius Oncology 50-day exponential moving average is 0.84 while CTOR share price is 1.40, making it a Buy technically.
- CTOR stock price is 1.40 and Citius Oncology 200-day simple moving average is 0.27, creating a Buy signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
- CTOR Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Citius Oncology is a Buy
- Citius Oncology Relative Strength Index (RSI) is 27.99, which suggest Citius Oncology is oversold
- The Bollinger Bands (25) for Citius Oncology is ( - ), which suggest Citius Oncology is a Buy
- The Bollinger Bands (100) for Citius Oncology is ( - ), which suggest Citius Oncology is a Buy
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.